NAT10 and familial pancreatic carcinoma: We employed single - cell analysis technology to thoroughly examine the binding of NAT10 and KRT8 to T - cell receptors, thereby gaining novel insights into the mechanism underlying NAT10 - regulated KRT8 - mediated immune suppression in pancreatic cancer through ac4C acetylation.